OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
1 min readOriginal
OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Originally published on
OpenAI News
Keep reading



